Alger Life Sciences Innovation Offshore Fund, LP — Form D/A
Alger Life Sciences Innovation Offshore Fund, LP of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2025-04-11. $4.4M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2025-04-11
- Form: D/A
- Accession: 0002005494-25-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $4.4M
- Minimum investment: $500K
- Investors: 8
- Date of first sale: 2024-01-01
- Security types: fund interests
- SEC file number: 021-501378
Issuer
- Name: Alger Life Sciences Innovation Offshore Fund, LP
- CIK: 0002005494
- Entity type: Limited Partnership
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2023
- Address: 100 PEARL STREET 27TH FLOOR, NEW YORK, NY, 10004
- Phone: 212-806-8800
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Daniel Cayley Chung | Executive Officer | New York, NY |
| Robert Louis Kincel | Executive Officer | New York, NY |
| Hal Cayley Liebes | Executive Officer | New York, NY |
| N/A Alger Alternative Holdings II, LLC | Promoter | New York, NY |
| N/A Fred Alger Management, LLC | Promoter | New York, NY |
| Daniel Cayley Chung | Related Person | New York, NY |
| Robert Louis Kincel | Related Person | New York, NY |
| Hal Liebes | Related Person | New York, NY |
Other filings by this issuer (3)
More